Stock Price Analysis of Teva Pharmaceutical Industries Limited (TEVA)

Lloyd Doyle
October 13, 2017

Cornercap Investment Counsel Inc who had been investing in Discovery Communicatns New Com for a number of months, seems to be bullish on the $7.27B market cap company. About 50,643 shares traded. It is down 55.47% since October 12, 2016 and is uptrending. It has underperformed by 17.58% the S&P500.

Teva Pharmaceutical Industries Limited is a pharmaceutical company. Hot Stocks Point (HSP) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. The hedge fund run by Jerome Pfund held 602,279 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $20.01 million, down from 753,821 at the end of the previous reported quarter. The company has a market capitalization of $16.07 billion, a PE ratio of 3.08 and a beta of 0.57. The analysts estimated mean EPS at 0.98 while the high and low EPS estimate stand at 1.14 and 0.85 respectively. About 178,253 shares traded.

Traders are paying renewed attention to shares of Teva Pharmaceutical Industries Ltd (TEVA). This is based on a scale where a 5 would indicate a Strong Buy, a 4 would equal a Moderate Buy, 3 a hold, 2 a moderate sell, and a rating of 1 would indicate a Strong Sell. Green Bancorp Inc had 15 analyst reports since August 3, 2015 according to SRatingsIntel. On Thursday, August 24 the stock rating was downgraded by Credit Suisse to "Underperform". Investors might also notice that three month ago the Buy recommendations (9) outnumbered Sell recommendations (0). Maxim Group maintained the shares of TEVA in report on Friday, August 4 with "Hold" rating. The firm earned "Outperform" rating on Thursday, October 15 by Cowen & Co. The firm has "Hold" rating given on Wednesday, August 2 by Mizuho. The rating was initiated by Piper Jaffray with "Overweight" on Wednesday, January 18. Goldman Sachs downgraded the stock to "Neutral" rating in Friday, July 15 report.

Investors sentiment decreased to 1.24 in 2017 Q2. Its down 0.14, from 0.96 in 2017Q1. However, the institutional investors are observed to own 60.20% of the total shares. 41 funds opened positions while 69 raised stakes.

The counter witnessed a trading volume of 6.95 million shares versus an average volume of 4.51 million shares during last trading session. 11,963 were accumulated by Peak6 Investments Lp. It is 0.00% or $0 reaching $179.79 per share.

Analysts await Kite Pharma Inc (NASDAQ:KITE) to report earnings on November, 8.

According to Newell Brands Inc.'s Insider ownership is at 0.30%. Fred Alger Mgmt reported 16,000 shares. Nationwide Fund Advisors holds 51,536 shares. 351,547 were accumulated by California State Teachers Retirement. Waddell And Reed Inc holds 0.23% of its portfolio in Kite Pharma Inc (NASDAQ:KITE) for 1.00M shares. (NASDAQ:DISCA) or 42,463 shares. 11,685 are owned by Arrow Financial Corp. Share performance for the month is now at 2.41%. It also reduced its holding in Pharmerica Corporation (NYSE:PMC) by 34,060 shares in the quarter, leaving it with 21,850 shares, and cut its stake in Lam Research Corp Com (NASDAQ:LRCX). This represents a $0.34 dividend on an annualized basis and a dividend yield of 2.16%. 2,400 shares were sold by Kim Helen Susan, worth $173,880. Nomura initiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Tuesday, September 29 with "Neutral" rating. Teva Pharmaceutical Industries Limited (TEVA) has made its way to a 12-month decline of -64.63%. They expect $1.05 earnings per share, down 17.97% or $0.23 from last year's $1.28 per share.

This stock (TEVA) is ahead of its 52-week low with 3.55%. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has "Buy" rating given on Tuesday, July 28 by Citigroup.

Sectoral Asset Management Inc, which manages about $3.30B and $914.42M US Long portfolio, upped its stake in Aerie Pharmaceuticals (NASDAQ:AERI) by 13,251 shares to 402,674 shares, valued at $21.16M in 2017Q2, according to the filing. It also upped Marriott Intl Inc New (NASDAQ:MAR) stake by 7,261 shares and now owns 7,761 shares.

Other reports by Iphone Fresh

Discuss This Article